1. Home
  2. BTDR vs MMSI Comparison

BTDR vs MMSI Comparison

Compare BTDR & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTDR

Bitdeer Technologies Group

HOLD

Current Price

$14.67

Market Cap

3.7B

Sector

Technology

ML Signal

HOLD

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$64.32

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTDR
MMSI
Founded
2021
1987
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BTDR
MMSI
Price
$14.67
$64.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
8
Target Price
$22.70
$98.88
AVG Volume (30 Days)
6.8M
800.1K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
4.93
EPS
N/A
0.68
Revenue
N/A
$1,515,906,000.00
Revenue This Year
$72.51
$8.85
Revenue Next Year
$40.84
$5.88
P/E Ratio
N/A
$93.42
Revenue Growth
N/A
11.75
52 Week Low
$7.04
$59.74
52 Week High
$27.80
$97.18

Technical Indicators

Market Signals
Indicator
BTDR
MMSI
Relative Strength Index (RSI) 61.56 48.64
Support Level $12.00 N/A
Resistance Level $14.86 $71.68
Average True Range (ATR) 1.21 1.96
MACD 0.04 0.51
Stochastic Oscillator 80.32 91.96

Price Performance

Historical Comparison
BTDR
MMSI

About BTDR Bitdeer Technologies Group

Bitdeer Technologies Group is principally engaged in the provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: